Cite

HARVARD Citation

    Price, A. et al. (n.d.). EP-1215: Do higher doses of palliative radiotherapy still prolong survival in stage III/IV NSCLC?. Radiotherapy and oncology. pp. S576-. [Online]. 
  
Back to record